NCT00591916

New Treatment for Donor Sites

• Status: Withdrawn
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: The University of Texas Medical Branch, Galveston · Academic / Other
• Sex: All
• Age: 1 Day – 90 Years
• Healthy volunteers: Not accepted

Summary

Primary research questions/Purpose of the Research. 1. Determine the short term (epidermal regeneration, reduction of pain, infections and length of stay) and long term (scarring, long term recovery, and cost of treatment) outcomes of Microbial Nanocellulose (NC) and fine mesh gauze impregnated with hyaluronan and thrombin (HT). 2. Determine if donor site treatment with NC and HT is as safe as the use of Scarlet Red ointment dressing. b. Describe the importance of the knowledge that you expect to gain from the research. To find a donor site dressing that has outcomes equal or better than that of scarlet red.

Conditions

• Burn

Interventions

Type	Name	Description
DRUG	Application of donor site dressing [scarlet red, Microbial Nanocellulose (NC), or hyaluronan and thrombin (HT)]	Application of donor site dressing: scarlet red, Microbial Nanocellulose (NC), or hyaluronan and thrombin (HT).
PROCEDURE	Blood sample	Obtain blood specimen at surgery donor site harvest, 14 days post surgery and 6 months post surgery
PROCEDURE	Biopsy	Tissue biopsy of donor site treated area at admission, wound healing and 2-6 months post burn.

Timeline

• Start date: 2006-01-01
• Primary completion: 2010-11-01
• Completion: 2010-11-01
• First posted: 2008-01-11
• Last updated: 2012-12-11